Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Cardiology · Coronary Artery Stenosis

Choosing a Procedure: Stents or Bypass Surgery

At a Glance

For coronary stenosis, stents (PCI) usually offer faster recovery, while bypass surgery (CABG) may be more durable for complex or multivessel disease. The best choice depends on symptoms, artery anatomy, diabetes, heart function, surgical risk, and personal goals.

When medications and lifestyle changes are not enough to control your heart symptoms, or if your anatomy is considered high-risk, your doctor may recommend revascularization. This is a medical term for a procedure that physically restores blood flow to the heart muscle. The two main ways to do this are PCI (stents) and CABG (bypass surgery).

Deciding between these two is not always simple. It involves weighing the complexity of your blockages against your overall health, surgical risk, and personal preferences [1][2].

When is a Procedure Needed?

For many patients with stable symptoms, medical therapy alone is just as safe as a procedure. However, revascularization becomes a priority in two main scenarios:

  1. Refractory Symptoms: You still experience unacceptable chest pain (angina) or shortness of breath despite being on optimized medications [3][4].
  2. High-Risk Anatomy or Acute Events: You are experiencing an Acute Coronary Syndrome, or tests show blockages in critical areas, such as the “Left Main” artery (the short main coronary trunk supplying the left side of the heart) or multiple major vessels combined with reduced heart pumping function [5][6].

Comparing Your Options: PCI vs. CABG

Neither procedure guarantees permanent symptom relief or prevents all future events, but each offers distinct trade-offs.

Percutaneous Coronary Intervention (PCI)

In this “minimally invasive” procedure, a doctor (interventional cardiologist) uses a catheter to place a small mesh tube called a stent into the narrowed artery to prop it open [7].

  • Benefits: No large incision, faster recovery (often home the next day), and a lower risk of early stroke [8][9].
  • Trade-offs: A higher chance that you will need a repeat procedure in the future, as stents can sometimes narrow again. Requires strict adherence to dual antiplatelet therapy. Carries small risks of bleeding, stent thrombosis (clotting), and contrast-induced kidney injury [10][11].

Coronary Artery Bypass Grafting (CABG)

This is a major surgery where a surgeon uses a healthy blood vessel from your chest, arm, or leg to “bypass” the blocked heart artery. While usually planned, it can sometimes be an urgent surgery [5].

  • Benefits: Generally more durable for complex disease. It is associated with fewer repeat procedures over the long term (5–10 years) [10][12].
  • Trade-offs: A longer recovery time (weeks to months), a larger incision, and risks including stroke, bleeding, infection, atrial fibrillation, wound complications, and kidney injury [8].

The “Heart Team” Approach

Because the choice between a stent and surgery can be complex, modern guidelines recommend a Heart Team approach for complicated cases [13]. This team is a group of specialists—including interventional cardiologists, heart surgeons, and imaging experts—who review your specific case together to provide a unified recommendation [14][9].

Research shows that following a Heart Team’s consensus improves the quality and transparency of the decision [15][16].

General Considerations: Which is Right for You?

While every patient is unique, doctors use established criteria to guide their recommendations. One common tool is the SYNTAX score, which grades the complexity of your artery blockages. The following are general tendencies, not absolute rules [17].

Factor Generally Favors PCI (Stents) Generally Favors CABG (Bypass)
Anatomy Single vessel or less complex blockages [2]. Complex, “diffuse” disease in many vessels [18][6].
Diabetes Less complex anatomy [19]. Multivessel disease with diabetes [20][21].
Heart Function Normal pumping (Ejection Fraction) [22]. Reduced heart pumping function [22][23].
Left Main Artery Low complexity (ostial/mid-shaft) [24]. High complexity (distal or multiple vessels) [2].

The Importance of “Complete Revascularization”

A key goal of any procedure is complete revascularization—treating the major blockages that are actively causing ischemia. This does not necessarily mean treating every angiographic narrowing, but rather the ones limiting flow. If a stent can safely address your ischemic lesions, it may be appropriate. If your disease is diffuse and CABG can provide a more complete bypass of all critical lesions, surgery is often favored for long-term health [25][26]. Incomplete treatment is linked to a higher risk of future heart events [27].

Common questions in this guide

When should coronary stenosis be treated with a procedure?
A procedure may be considered when chest pain or shortness of breath remains unacceptable despite well-adjusted medicines, or when there is a sudden heart-related event or high-risk anatomy. Examples include a blockage in the left main coronary artery or disease in several major vessels with reduced heart pumping. For many people with stable symptoms, medication and lifestyle treatment may be as safe as a procedure.
What is the difference between a stent and bypass surgery?
PCI uses a catheter to place a mesh stent in the narrowed artery, usually without a large incision, so recovery is faster. CABG is major surgery that uses a healthy blood vessel to route blood around blockages, so recovery takes longer. PCI may require another procedure later and antiplatelet medication, while CABG is more invasive but often lasts longer for complex disease.
Is bypass surgery better than stents if I have diabetes or several blockages?
Not automatically; the best option depends on the complexity and location of the blockages, heart function, other health conditions, and personal priorities. Bypass surgery is often favored for complex disease in several vessels, particularly when diabetes or reduced heart pumping is present, while stents may suit less complex anatomy. A Heart Team can compare the benefits and risks for your specific case.
What does a Heart Team do when choosing between PCI and CABG?
A Heart Team brings together an interventional cardiologist, a heart surgeon, and imaging specialists to review your symptoms, artery anatomy, overall health, and treatment goals. The team uses this shared review to recommend the option most likely to provide a safe and complete treatment. You can also ask how each specialist views the long-term trade-offs.
How does the SYNTAX score affect my treatment choice?
The SYNTAX score estimates how complex the blockages in the coronary arteries are. A higher-complexity pattern may make bypass surgery more appropriate, while simpler disease may be suitable for stents. The score is one factor among many and should be interpreted with your heart function, other conditions, and preferences.
What does complete revascularization mean for stents or bypass surgery?
Complete revascularization means treating the major blockages that are limiting blood flow to the heart, rather than automatically treating every narrowing seen on an angiogram. A stent may be appropriate if it can safely treat the important blockages. Bypass surgery may be favored when disease is widespread and bypassing several critical areas would provide more complete treatment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my SYNTAX score, and how does that number influence whether you recommend a stent or bypass surgery?
  2. 2.Can 'complete revascularization' be achieved with a stent in my case, or is my disease too diffuse for that?
  3. 3.Given my other conditions (like diabetes or reduced heart function), what are the long-term trade-offs between PCI and CABG for me?
  4. 4.Will my case be reviewed by a multidisciplinary 'Heart Team,' and what was the surgeon's perspective on my anatomy?
  5. 5.If we choose a stent, what is the likelihood that I will need a repeat procedure in the next five years compared to bypass surgery?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (27)
  1. 1

    2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

    , Virani SS, Newby LK, et al.

    Journal of the American College of Cardiology 2023; (82(9)):833-955 doi:10.1016/j.jacc.2023.04.003.

    PMID: 37480922
  2. 2

    2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.

    Byrne RA, Fremes S, Capodanno D, et al.

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2023; (64(2)) doi:10.1093/ejcts/ezad286.

    PMID: 37632766
  3. 3

    Advances in Management of Stable Coronary Artery Disease: the Role of Revascularization?

    Voudris KV, Kavinsky CJ

    Current treatment options in cardiovascular medicine 2019; (21(3)):15 doi:10.1007/s11936-019-0720-9.

    PMID: 30854580
  4. 4

    Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease.

    Vafaei P, Naderi S, Ambrosy AP, Slade JJ

    Current atherosclerosis reports 2021; (23(11)):70 doi:10.1007/s11883-021-00970-z.

    PMID: 34468881
  5. 5

    Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week.

    Boden WE, Marzilli M, Crea F, et al.

    Journal of the American College of Cardiology 2023; (81(5)):505-514 doi:10.1016/j.jacc.2022.08.814.

    PMID: 36725179
  6. 6

    It's not all about ISCHEMIA: the case for coronary artery bypass grafting in stable coronary artery disease.

    Yan W, Eikelboom R, Muller Moran HR, Arora RC

    Current opinion in cardiology 2022; (37(6)):459-467 doi:10.1097/HCO.0000000000000994.

    PMID: 36094460
  7. 7

    Left Main Coronary Artery Disease: Secular Trends in Patient Characteristics, Treatments, and Outcomes.

    Lee PH, Ahn JM, Chang M, et al.

    Journal of the American College of Cardiology 2016; (68(11)):1233-1246 doi:10.1016/j.jacc.2016.05.089.

    PMID: 27609687
  8. 8

    Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.

    Head SJ, Milojevic M, Daemen J, et al.

    Journal of the American College of Cardiology 2018; (72(4)):386-398 doi:10.1016/j.jacc.2018.04.071.

    PMID: 30025574
  9. 9

    Lack of implementation of guidelines recommendations for coronary revascularization in stable patients with complex disease is associated with high rates of incomplete revascularization : Analysis from the Apache study.

    Marino M, Leonardi S, Crimi G, et al.

    Heart and vessels 2020; (35(1)):30-37 doi:10.1007/s00380-019-01459-1.

    PMID: 31222553
  10. 10

    Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-Up Outcomes of Multicenter Randomized Controlled BEST Trial.

    Ahn JM, Kang DY, Yun SC, et al.

    Circulation 2022; (146(21)):1581-1590 doi:10.1161/CIRCULATIONAHA.122.062188.

    PMID: 36121700
  11. 11

    Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.

    Stone GW, Kappetein AP, Sabik JF, et al.

    The New England journal of medicine 2019; (381(19)):1820-1830 doi:10.1056/NEJMoa1909406.

    PMID: 31562798
  12. 12

    Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.

    Lee CW, Ahn JM, Cavalcante R, et al.

    JACC. Cardiovascular interventions 2016; (9(24)):2481-2489 doi:10.1016/j.jcin.2016.10.008.

    PMID: 28007199
  13. 13

    The Heart Team for Coronary Revascularization Decisions: 2 Illustrative Cases.

    Metkus TS, Beckie TM, Cohen MG, et al.

    JACC. Case reports 2022; (4(3)):115-120 doi:10.1016/j.jaccas.2021.12.005.

    PMID: 35199000
  14. 14

    [The heart team in planning and performance of revascularization : ESC guidelines versus clinical routine].

    Sinning JM, Welz A, Nickenig G

    Herz 2016; (41(7)):562-565 doi:10.1007/s00059-016-4477-6.

    PMID: 27596003
  15. 15

    Heart Team/Guidelines Discordance Is Associated With Increased Mortality: Data From a National Survey of Revascularization in Patients With Complex Coronary Artery Disease.

    Witberg G, Segev A, Barac YD, et al.

    Circulation. Cardiovascular interventions 2021; (14(1)):e009686 doi:10.1161/CIRCINTERVENTIONS.120.009686.

    PMID: 33423541
  16. 16

    Prognostic Impact of Implementation of Heart Team Approach on Cardiovascular Outcomes in Patients With Complex Coronary Artery Disease.

    Su PH, Huang YL, Chen PW, et al.

    Clinical cardiology 2025; (48(5)):e70141 doi:10.1002/clc.70141.

    PMID: 40317546
  17. 17

    Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease.

    Escaned J, Banning A, Farooq V, et al.

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2016; (12(2)):e224-34.

    PMID: 27290681
  18. 18

    Weighing Coronary Revascularization Options in Patients With Type 2 Diabetes Mellitus.

    Godoy LC, Tavares CAM, Farkouh ME

    Canadian journal of diabetes 2020; (44(1)):78-85 doi:10.1016/j.jcjd.2019.08.002.

    PMID: 31594759
  19. 19

    Drug-Eluting Stent Versus Coronary Artery Bypass Grafting for Diabetic Patients With Multivessel and/or Left Main Coronary Artery Disease: A Meta-Analysis.

    Cui K, Lyu S, Song X, et al.

    Angiology 2019; (70(8)):765-773 doi:10.1177/0003319719839885.

    PMID: 30995117
  20. 20

    Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study.

    Farkouh ME, Domanski M, Dangas GD, et al.

    Journal of the American College of Cardiology 2019; (73(6)):629-638 doi:10.1016/j.jacc.2018.11.001.

    PMID: 30428398
  21. 21

    Causes of Death After Coronary Revascularization in Patients With Diabetes.

    Godoy LC, Fuster V, Razzouk L, et al.

    The Annals of thoracic surgery 2025; (119(6)):1251-1260 doi:10.1016/j.athoracsur.2024.12.013.

    PMID: 39725250
  22. 22

    Short-term and long-term outcomes of revascularization interventions for patients with severely reduced left ventricular ejection fraction: a meta-analysis.

    Pei J, Wang X, Xing Z, et al.

    ESC heart failure 2021; (8(1)):634-643 doi:10.1002/ehf2.13141.

    PMID: 33274612
  23. 23

    STICH3C: Rationale and Study Protocol.

    Fremes SE, Marquis-Gravel G, Gaudino MFL, et al.

    Circulation. Cardiovascular interventions 2023; (16(8)):e012527 doi:10.1161/CIRCINTERVENTIONS.122.012527.

    PMID: 37582169
  24. 24

    Unprotected Left Main Coronary Artery Disease: Management in the Post NOBLE and EXCEL Era.

    Borges N, Kapadia SR, Ellis SG

    Interventional cardiology (London, England) 2017; (12(2)):92-96 doi:10.15420/icr.2017:18:2.

    PMID: 29588736
  25. 25

    Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.

    Ahn JM, Park DW, Lee CW, et al.

    JACC. Cardiovascular interventions 2017; (10(14)):1415-1424 doi:10.1016/j.jcin.2017.04.037.

    PMID: 28728654
  26. 26

    Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: A meta-analysis of randomized and observational studies.

    Zimarino M, Ricci F, Romanello M, et al.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2016; (87(1)):3-12 doi:10.1002/ccd.25923.

    PMID: 25846673
  27. 27

    Everolimus-eluting stents or bypass surgery for multivessel coronary disease.

    Bangalore S, Guo Y, Samadashvili Z, et al.

    The New England journal of medicine 2015; (372(13)):1213-22 doi:10.1056/NEJMoa1412168.

    PMID: 25775087

This page is for informational purposes only and does not constitute medical advice. It explains how a cardiology team compares PCI and CABG for coronary stenosis; discuss your symptoms, anatomy, and personal risks with your own care team.

Get notified when new evidence is published on coronary stenosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.